Search

Author/Creator Dürig, J.

1. DRUG PERTURBATION BASED STRATIFICATION OF LYMPHOPROLIFERATIVE DISORDERS. (June 2017)

Authors:
Dietrich, S.; Oleś, M.; Sellner, L.; Anders, S.; Lu, J.; Velten, B.; Mock, A.; Oakes, C.; Sutton, L.; Young, E.; Rosenquist, R.; Rossi, D.; Zirlik, K.; Herling, M.; Nguyen‐Khac, F.; Plass, C.; von Kalle, C.; Dürig, J.; Ringshausen, I.; Huber, W.
Journal:
Hematological oncology
Issue:
Volume 35(2017)Supplement 2
Page Start:
56
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. IMMUNOCHEMOTHERAPY WITH OBINUTUZUMAB OR RITUXIMAB IN PREVIOUSLY UNTREATED FOLLICULAR LYMPHOMA IN THE RANDOMISED PHASE III GALLIUM STUDY: ANALYSIS BY CHEMOTHERAPY REGIMEN. (June 2017)

Authors:
Hiddemann, W.; Barbui, A.M.; Canales Albendea, M.A.; Cannell, P.K.; Collins, G.P.; Dürig, J.; Forstpointner, R.; Herold, M.; Hertzberg, M.; Klanova, M.; Radford, J.A.; Tobinai, K.; Burciu, A.; Fingerle‐Rowson, G.R.; Nielsen, T.; Wolbers, M.; Marcus, R.
Journal:
Hematological oncology
Issue:
Volume 35(2017)Supplement 2
Page Start:
117
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. P879: EXENT AND FLC MASS SPECTROMETRY FOR SEROLOGICAL IDENTIFICATION AND QUANTIFICATION OF MONOCLONAL IMMUNOGLOBULINS IN MULTIPLE MYELOMA. (23rd June 2022)

Authors:
Huhn, S.; Poos, A. M.; Mai, E. K.; Hänel, M.; Salwender, H. J.; Dürig, J.; Blau, I. W.; Scheid, C.; Weisel, K. C.; Munder, M.; Berlanga, O.; Bertsch, U.; Goldschmidt, H.; Weinhold, N.
Journal:
HemaSphere
Issue:
Volume 6(2022)Supplement 3
Page Start:
771
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. P930: ISATUXIMAB, LENALIDOMIDE, BORTEZOMIB AND DEXAMETHASONE AS INDUCTION THERAPY FOR NEWLY-DIAGNOSED MULTIPLE MYELOMA PATIENTS WITH HIGH-RISK CYTOGENETICS: A SUBGROUP ANALYSIS FROM THE GMMG-HD7 TRIAL. (23rd June 2022)

Authors:
Mai, E. K.; Bertsch, U.; Fenk, R.; Tichy, D.; Besemer, B.; Dürig, J.; Schroers, R.; von Metzler, I.; Hänel, M.; Mann, C.; Asemissen, A. M.; Heilmeier, B.; Nievergall, E.; Huhn, S.; Kriegsmann, K.; Weinhold, N.; Luntz, S.; Holderrried, T. A. W.; Trautmann-Grill, K.; Gezer, D.
Journal:
HemaSphere
Issue:
Volume 6(2022)Supplement 3
Page Start:
820
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. UNMAINTAINED REMISSION AFTER DISCONTINUATION OF KINASE INHIBITOR TREATEMENT IN CHRONIC LYMPHOCYTIC LEUKEMIA: AN OBSERVATIONAL COHORT. (12th June 2019)

Authors:
Egle, A.; Jäger, U.; Skrabs, C.; Dürig, J.; Nösslinger, T.; Wanner, D.; Steurer, M.; Ringshausen, I.; Melchardt, T.; Greil, R.; Ysebaert, L.
Journal:
Hematological oncology
Issue:
Volume 37(2019)Supplement 2
Page Start:
218
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗